Longevity science just hit an inflection point. We're witnessing the shift from slowing aging to reversing it - epigenetic reprogramming, senolytics, gene therapy, and AI converging to extend healthspan. This week marks when the paradigm changed from defense to engineering. Discover the 7 breakthroughs reshaping aging biology: - Epigenetic Reprogramming in Humans: Life Biosciences achieved FDA clearance for ER-100, the first human trial delivering Yamanaka factors to reverse vision loss - the undo button for aging. - The Biological Timeline Rewritten: Analysis of 135,000 molecules reveals aging happens in distinct cliffs at ages 44 and 60, fundamentally changing intervention strategies. - Senolytic Breakthroughs: Combining senolytics like ABT-263 with metabolic interventions dramatically enhances clearance of senescent cells - the biological zombies driving age-related decline. - Automated Cell Manufacturing: Cellino Bio's AI platform scales personalized iPSC therapies, democratizing regenerative medicine through cost reduction and consistency. - Gene Editing Without DNA Repair: Eli Lilly's partnership with Seamless Therapeutics enables precise edits for heritable hearing loss and genetic conditions. - Metabolic Regulators as Multi-System Therapies: GLP-1 agonists address cardiovascular disease, kidney dysfunction, and metabolic aging simultaneously. - AI-Driven Biomarker Discovery: Machine learning analyzing 100+ million health records identifies aging biomarkers and drug targets with unprecedented precision. What connects these breakthroughs: aging is a constellation of interconnected failures across cellular, metabolic, and genetic domains. We now possess precision instruments to address root causes, not symptoms. The next decade won't resemble the last. Subscribe to Tomorrow Unveiled for insights into technologies shaping our future. #LongevityScience #AgeReversal #EpigeneticReprogramming #GeneTherapy #Healthspan #Senolytics #RegenerativeMedicine #GeroscientificallyGrounded
Watch on YouTube: https://www.youtube.com/watch?v=ynIz99st5Lk
